Results 221 to 230 of about 85,660 (309)

IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α-Cofilin-1 Axis in Cutaneous T-cell Lymphoma. [PDF]

open access: yesMol Cancer Res
Mukherjee D   +11 more
europepmc   +1 more source

Aosta Valley animal cancer registry: A collaborative initiative for monitoring cancer burden in animals

open access: yesVeterinary Record Open, Volume 13, Issue 1, June 2026.
Abstract Background Animal cancer registry data are important for monitoring animal health, for prevention and research in veterinary medicine, and for comparative oncology. Since people and animals share the same environment and are exposed to many common risk factors, cancer patterns in animals may have a sentinel function for human health.
Claudio Trentin   +10 more
wiley   +1 more source

New and emerging therapies in cutaneous T-cell lymphoma. [PDF]

open access: yesDermatol Reports
Roccuzzo G   +4 more
europepmc   +1 more source

Personalized Cancer Vaccines in the Clinical Trial Pipeline

open access: yesAsia-Pacific Journal of Clinical Oncology, Volume 22, Issue 3, Page 362-368, June 2026.
ABSTRACT Aim To present an overview of personalized cancer vaccines currently undergoing clinical development, aiming to enhance awareness and promote collaboration among academic, commercial researchers, and non‐profit communities. Methods A dataset of 78 clinical trials for personalized cancer vaccines was generated using ClinicalTrials.gov database ...
Liudmila Iamukova, Elena Alferova
wiley   +1 more source

Clinical and Prognostic Features of Erythrodermic Cutaneous T-Cell Lymphoma: A Retrospective Study of 35 Patients [PDF]

open access: yesTurk J Haematol
Şanlı H   +5 more
europepmc   +1 more source

What Is Your Diagnosis? Cutaneous Mass in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Ester Quilez, Shannon L. Donahoe
wiley   +1 more source

Fenofibrate potentiates the therapeutic efficacy of EZH2 inhibitors on melanoma via TRIM21‐ and OTUD4‐mediated EZH2 ubiquitination

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 11, Page 2675-2694, June 2026.
Background and Purpose EZH2 (enhancer of zeste homologue 2) inhibitors are an emerging class of drugs that target epigenetic regulation. However, their efficacy in solid tumours has been limited, partly due to drug‐induced upregulation of fatty acid synthesis.
Rui Cheng   +10 more
wiley   +1 more source

CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention. [PDF]

open access: yesLeukemia
Isabelle C   +12 more
europepmc   +1 more source

What Is Your Diagnosis? Multiple Subcutaneous Lumps in a Horse

open access: yes
Veterinary Clinical Pathology, EarlyView.
Federica Meistro   +4 more
wiley   +1 more source

Oral Angiolymphoid Hyperplasia With Eosinophilia Exhibiting Cutaneous‐Type Histopathologic Features: Clinical Regression Following Hormonal Withdrawal and a 50‐Year Review

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 6, Page 491-501, June 2026.
Case report of a 30‐year‐old female. Asymptomatic, red‐purple hyperplastic lesion extending from teeth 21 to 25, with bleeding upon manipulation. Differential diagnosis included: inflammatory gingival hyperplasia, plasma cell gingivitis, leukemia, and Wegener's granulomatosis.
Pedro Vinícius Santos de Jesus   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy